189
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Ginkgo biloba Extract Reduces Hippocampus Inflammatory Responses, Improves Cardiac Functions And Depressive Behaviors In A Heart Failure Mouse Model

, , &
Pages 3041-3050 | Published online: 29 Oct 2019

References

  • Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet (London, England). 2017;390(10100):1211–1259. doi:10.1016/S0140-6736(17)32154-2
  • Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.28122885
  • Angermann CE, Gelbrich G, Stork S, et al. Somatic correlates of comorbid major depression in patients with systolic heart failure. Int J Cardiol. 2011;147(1):66–73. doi:10.1016/j.ijcard.2009.07.04419716613
  • Faller H, Stork S, Schuler M, et al. Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure–a structural equation modeling approach. J Card Fail. 2009;15(4):286–292.e282. doi:10.1016/j.cardfail.2008.10.02219398075
  • Husain MI, Chaudhry IB, Husain MO, et al. Depression and congestive heart failure: a large prospective cohort study from Pakistan. J Psychosom Res. 2019;120:46–52. doi:10.1016/j.jpsychores.2019.03.00830929707
  • Su J, Wang J, Ma Y, et al. Inflammation associated with chronic heart failure leads to enhanced susceptibility to depression. FEBS J. 2019. doi:10.1111/febs.14839
  • Frey A, Popp S, Post A, et al. Experimental heart failure causes depression-like behavior together with differential regulation of inflammatory and structural genes in the brain. Front Behav Neurosci. 2014;8:376. doi:10.3389/fnbeh.2014.0037625400562
  • Liu M, Liu J, Zhang L, Geng Q, Ge Y. Antidepressant-like effects of ginseng fruit saponin in myocardial infarction mice. Biomed Pharmacother. 2019;115:108900. doi:10.1016/j.biopha.2019.10890031054510
  • Jokinen J, Nordstrom P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord. 2009;116(1–2):88–92. doi:10.1016/j.jad.2008.10.02519054568
  • Majidi J, Kosari-Nasab M, Salari AA. Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice. Brain Res Bull. 2016;120:1–13. doi:10.1016/j.brainresbull.2015.10.00926521068
  • Hemrick-Luecke SK, Evans DC. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis. Neuropharmacology. 2002;42(2):162–169. doi:10.1016/S0028-3908(01)00166-611804612
  • Vogelzangs N, Beekman AT, Milaneschi Y, Bandinelli S, Ferrucci L, Penninx BW. Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J Clin Endocrinol Metab. 2010;95(11):4959–4964. doi:10.1210/jc.2010-019220739384
  • Sun T, Wang X, Xu H. Ginkgo biloba extract for angina pectoris: a systematic review. Chin J Integr Med. 2015;21(7):542–550. doi:10.1007/s11655-015-2070-025749902
  • Kang JM, Lin S. Ginkgo biloba and its potential role in glaucoma. Curr Opin Ophthalmol. 2018;29(2):116–120. doi:10.1097/ICU.000000000000045929206653
  • Tulsulkar J, Glueck B, Hinds TD Jr, Shah ZA. Ginkgo biloba extract prevents female mice from ischemic brain damage and the mechanism is independent of the HO1/Wnt pathway. Transl Stroke Res. 2016;7(2):120–131. doi:10.1007/s12975-015-0433-726573919
  • Dai CX, Hu CC, Shang YS, Xie J. Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B. Medicine. 2018;97(39):e12421. doi:10.1097/MD.000000000001242130278520
  • Diamond BJ, Bailey MR. Ginkgo biloba: indications, mechanisms, and safety. Psychiatr Clin North Am. 2013;36(1):73–83. doi:10.1016/j.psc.2012.12.00623538078
  • Liu L, Dong Y, Shan X, Li L, Xia B, Wang H. Anti-depressive effectiveness of baicalin in vitro and in vivo. Molecules. 2019;24(2):326. doi:10.3390/molecules24020326
  • Sivukhina EV, Poskrebysheva AS, Smurova IV, et al. Altered hypothalamic-pituitary-adrenal axis activity in patients with chronic heart failure. Horm Metab Res. 2009;41(10):778–784. doi:10.1055/s-0029-122418219544245
  • Juruena MF, Bocharova M, Agustini B, Young AH. Atypical depression and non-atypical depression: is HPA axis function a biomarker? A systematic review. J Affect Disord. 2018;233:45–67. doi:10.1016/j.jad.2017.09.05229150144
  • Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34. doi:10.1038/nri.2015.526711676
  • Ter Maaten JM, Damman K, Verhaar MC, et al. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail. 2016;18(6):588–598. doi:10.1002/ejhf.2016.18.issue-626861140
  • Rajeswaran T, Plymen CM, Doherty AM. The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression - a systematic review. Int J Psychiatry Clin Pract. 2018;22(3):164–169. doi:10.1080/13651501.2017.140108529172802
  • Brouwers C, Christensen SB, Damen NL, et al. Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression. Int J Cardiol. 2016;203:867–873. doi:10.1016/j.ijcard.2015.11.03226599753
  • Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993;614(1–2):37–44. doi:10.1016/0006-8993(93)91015-K8348328
  • Nichols CD. Serotonin 5-HT(2A) receptor function as a contributing factor to both neuropsychiatric and cardiovascular diseases. Cardiovasc Psychiatry Neurol. 2009;2009:475108. doi:10.1155/2009/47510820029624
  • Suzuki H, Sumiyoshi A, Matsumoto Y, et al. Structural abnormality of the hippocampus associated with depressive symptoms in heart failure rats. NeuroImage. 2015;105:84–92. doi:10.1016/j.neuroimage.2014.10.04025462699
  • Suzuki H, Matsumoto Y, Ota H, et al. Hippocampal blood flow abnormality associated with depressive symptoms and cognitive impairment in patients with chronic heart failure. Circ J. 2016;80(8):1773–1780. doi:10.1253/circj.CJ-16-036727295999
  • Wu H, Denna TH, Storkersen JN, Gerriets VA. Beyond a neurotransmitter: the role of serotonin in inflammation and immunity. Pharmacol Res. 2019;140:100–114. doi:10.1016/j.phrs.2018.06.01529953943
  • Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13(7):717–728. doi:10.1038/sj.mp.400205517700577
  • Li B, Wang B, Chen M, Li G, Fang M, Zhai J. Expression and interaction of TNF-alpha and VEGF in chronic stress-induced depressive rats. Exp Ther Med. 2015;10(3):863–868. doi:10.3892/etm.2015.264126622406
  • Nigmatullina RR, Kirillova VV, Jourjikiya RK, et al. Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment. Cardiology. 2009;113(4):277–286. doi:10.1159/00020596219270454
  • Ramage AG. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull. 2001;56(5):425–439. doi:10.1016/S0361-9230(01)00612-811750788
  • Mantle D, Wilkins RM, Gok MA. Comparison of antioxidant activity in commercial Ginkgo biloba preparations. J Altern Complement Med. 2003;9(5):625–629. doi:10.1089/10755530332252447214629840
  • Woelkart K, Feizlmayr E, Dittrich P, et al. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans. Phytother Res. 2010;24(3):445–450. doi:10.1002/ptr.v24:320041430
  • Cao Guoxiu LW, Hui Y. Rapid identification of constituents from different Ginkgo biloba preparations by high resolution mass spectrometry and metabolomics technology. J China Pharm Univ. 2018;49(4):441–448.
  • Liang Z, Bai S, Shen P, et al. GC-MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampus. Behav Brain Res. 2016;314:116–124. doi:10.1016/j.bbr.2016.08.00127498146
  • Mak YT, Chan WY, Lam WP, Yew DT. Immunohistological evidences of Ginkgo biloba extract altering Bax to Bcl-2 expression ratio in the hippocampus and motor cortex of senescence accelerated mice. Microsc Res Tech. 2006;69(8):601–605. doi:10.1002/(ISSN)1097-002916721734
  • Panda VS, Naik SR. Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol. 2008;60(4–5):397–404. doi:10.1016/j.etp.2008.03.01018513933
  • El-Boghdady NA. Increased cardiac endothelin-1 and nitric oxide in adriamycin-induced acute cardiotoxicity: protective effect of Ginkgo biloba extract. Indian J Biochem Biophys. 2013;50(3):202–209.23898483
  • Yang B, Ye D, Wang Y. Caspase-3 as a therapeutic target for heart failure. Expert Opin Ther Targets. 2013;17(3):255–263. doi:10.1517/14728222.2013.74551323294432
  • Francis GS, Anwar F, Bank AJ, Kubo SH, Jessurun J. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device. J Card Fail. 1999;5(4):308–315. doi:10.1016/S1071-9164(99)91335-010634672
  • Moorjani N, Westaby S, Narula J, et al. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure. Am J Cardiol. 2009;103(9):1261–1268. doi:10.1016/j.amjcard.2009.01.01319406269
  • Dias S, Shmelkov SV, Lam G, Rafii S. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood. 2002;99(7):2532–2540. doi:10.1182/blood.V99.7.253211895790
  • Heider U, Kaiser M, Sterz J, et al. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Eur J Haematol. 2006;76(1):42–50. doi:10.1111/EJH.2006.76.issue-116343270
  • Fu JD, Yao JJ, Wang H, et al. Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1alpha and VEGF under a hypoxic state. Eur Rev Med Pharmacol Sci. 2019;23(1):155–161. doi:10.26355/eurrev_201901_1675930657557
  • de Meirelles LR, Resende Ade C, Matsuura C, et al. Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure. Clin Exp Pharmacol Physiol. 2011;38(10):705–710. doi:10.1111/j.1440-1681.2011.05580.x21806669
  • Kim JH, Shah P, Tantry US, Gurbel PA. Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications. Curr Heart Fail Rep. 2016;13(6):319–328. doi:10.1007/s11897-016-0308-627815681